Evaluation of the safety and efficacy in linagliptin with type 2 diabetic patients receiving hemodialysis therapy
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Sep 2015 Status changed from not yet recruiting to discontinued, as reported by University Hospital Medical Information Network - Japan record.
- 09 Apr 2013 New trial record